Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Micro-X Ltd. ( (AU:MX1) ) has issued an update.
Micro-X Ltd has successfully achieved significant development milestones on time and within budget for its contracts with ARPA-H and Billion Prima, enhancing its position in the health and security markets. The company completed Milestone 3 for a Full Body CT scanner under its ARPA-H contract and Milestone 2 for a baggage and parcel scanning unit with Billion Prima. These achievements underscore Micro-X’s commitment to timely project delivery and its strategic partnerships, which are crucial for its growth and market expansion.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Limited is an ASX listed hi-tech company that develops and commercializes innovative products for global health and security markets using proprietary cold cathode, carbon nanotube emitter technology. This technology allows for x-ray products that are smaller, lighter, and require less power, enhancing mobility and usability. The company operates a fully integrated design and production facility in Adelaide, Australia, and is expanding its US business with a growing team in Seattle. Micro-X’s product portfolio includes mobile digital radiology products for healthcare, military, and veterinary applications, and it is contracted by the US Department of Homeland Security to design a next-generation airport security checkpoint.
Average Trading Volume: 249,636
Technical Sentiment Signal: Sell
Current Market Cap: A$29.36M
See more data about MX1 stock on TipRanks’ Stock Analysis page.